Log in
Enquire now
Nanoligent

Nanoligent

Nanoligent is a developer of precision nanodrugs for cancer treatment founded in 2017 by Ramon Mangues.

OverviewStructured DataIssuesContributors

Contents

nanoligent.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Biotechnology
Biotechnology
Engineering
Engineering
Manufacturing
Manufacturing
Pharmaceutical industry
Pharmaceutical industry
Health technology
Health technology
Biomedical engineering
Biomedical engineering
Location
Spain
Spain
B2X
B2B
B2B
CEO
‌
Montserrat Cano Biosca
Founder
‌
Manuel Rodriguez
‌
Ramon Mangues
Pitchbook URL
pitchbook.com/profiles...491189-50
Number of Employees (Ranges)
1 – 10
Email Address
email@nanoligent.com
Investors
‌
AVANTECA Partners
IAG Capital Partners
IAG Capital Partners
Centre for the Development of Industrial Technology
Centre for the Development of Industrial Technology
Italian Angels for Growth
Italian Angels for Growth
‌
Clave Capital
Inveready Technology Investment Group
Inveready Technology Investment Group
‌
i&i Biotech Fund
Founded Date
January 1, 2017
Total Funding Amount (USD)
16,900,000
Latest Funding Round Date
October 10, 2025
Latest Funding Type
Series A
Series A
Country
Spain
Spain
Headquarters
Barcelona
Barcelona

Other attributes

Latest Funding Round Amount (USD)
14,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Nanoligent

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.